Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hpv”

2,051 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,051 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05314023
What this trial is testing

Immunogenicity and Safety of V503 in Chinese Males 9 Through 19 Years Old (V503-053)

Who this might be right for
Genital Warts
Merck Sharp & Dohme LLC 1,590
Not applicableUnknownNCT03942380
What this trial is testing

Cell-free Tumor DNA in Head and Neck Cancer Patients

Who this might be right for
Head and Neck CancerHead and Neck NeoplasmsHead and Neck Squamous Cell Carcinoma+24 more
Christian von Buchwald 500
Post-approval studies (Phase 4)Study completedNCT01571141
What this trial is testing

Polyhexamethylene Biguanide Increases the Regression Rate of Human Papillomavirus (HPV) Infection

Who this might be right for
HPV Infection
AGUNCO Obstetrics and Gynecology Centre
Not applicableNot Yet RecruitingNCT06631794
What this trial is testing

Evaluation of the Impact of a HPV Vaccination Talk with Third Grade Students

Who this might be right for
Teenagers
Hopital Foch 1,170
Not applicableLooking for participantsNCT06513494
What this trial is testing

Active Health Education to Increase HPV Vaccine Coverage in Youth: A Stepped-wedge, Cluster, and Randomized Trial

Who this might be right for
Vaccine RefusalVaccine Hesitancy
Hospital Israelita Albert Einstein 5,000
Large-scale testing (Phase 3)Study completedNCT00779766
What this trial is testing

Efficacy, Immunogenicity and Safety of GSK Biologicals' HPV GSK 580299 Vaccine in Healthy Chinese Female Subjects

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 6,081
Large-scale testing (Phase 3)Study completedNCT01969877
What this trial is testing

Cisplatin Plus Radiotherapy Compared to Cetuximab Plus Radiotherapy in Locally Advanced Head and Neck Cancer.

Who this might be right for
Locally Advanced Head and Neck Cancer
Lund University Hospital 298
Not applicableStudy completedNCT03436251
What this trial is testing

Local Hyperthermia for the Treatment of Cervical Intraepithelial Neoplasias

Who this might be right for
Cervical Intraepithelial NeoplasiaHuman Papilloma Virus
First Hospital of China Medical University 53
Large-scale testing (Phase 3)Ended earlyNCT05937672
What this trial is testing

Cold Atmospheric Plasma Device Extension Study

Who this might be right for
Verruca VulgarisMolluscum Contagiosum
Medical University of South Carolina 60
Not applicableWithdrawnNCT03609372
What this trial is testing

The STOP-HPV Trial 6: Single Arm Evaluation of the Maintenance of the STOP-HPV Bundle

Who this might be right for
VaccinationImmunization
University of California, Los Angeles
Early research (Phase 1)Study completedNCT03578406
What this trial is testing

HPV-E6-Specific Anti-PD1 TCR-T Cells in the Treatment of HPV-Positive NHSCC or Cervical Cancer

Who this might be right for
Cervical CancerHead and Neck Squamous Cell Carcinoma
Xinqiao Hospital of Chongqing 9
Post-approval studies (Phase 4)UnknownNCT04270773
What this trial is testing

Immunogenicity and Safety of a 9-valent Human Papillomavirus Vaccine in HIV-positive Women

Who this might be right for
HIV InfectionsHPV Infection
University Hospital Virgen de las Nieves 158
Not applicableStudy completedNCT04746872
What this trial is testing

Alinity m HR HPV Specimen Collection Study From Women Undergoing Routine Cervical Cancer Screening

Who this might be right for
Human Papillomavirus
Abbott Molecular 14,935
Testing effectiveness (Phase 2)Active Not RecruitingNCT04862650
What this trial is testing

Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell Carcinoma+22 more
Marcelo Bonomi
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07775313
What this trial is testing

Base-Edited Hematopoietic Stem/Progenitor Cell Gene Therapy for Treatment of CXCR4-WHIM

Who this might be right for
WHIMWartsHypogammaglobulinemia+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 10
Not applicableLooking for participantsNCT06808776
What this trial is testing

Stories to Prevent (StoP) HPV Cancers

Who this might be right for
Human Papillomavirus VaccinationEmotions
Milton S. Hershey Medical Center 200
Testing effectiveness (Phase 2)Study completedNCT01530997
What this trial is testing

De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca

Who this might be right for
Carcinoma, Squamous CellHead and Neck NeoplasmsOropharyngeal Neoplasms
UNC Lineberger Comprehensive Cancer Center 45
Early research (Phase 1)Active Not RecruitingNCT05075993
What this trial is testing

Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors

Who this might be right for
Metastatic EsophagealGastric CancerMetastatic Head and Neck Carcinoma+5 more
M.D. Anderson Cancer Center 352
Not applicableLooking for participantsNCT06574087
What this trial is testing

Determining the Frequency of Occurrence and Defining the Most Appropriate Screening Test for Anal Intraepithelial Neoplasia (AIN) in Patients With Human Papillomavirus (HPV) Related Gynecological Diseases.

Who this might be right for
HPV-Related CarcinomaHPV Infection
PCK Marine Hospital in Gdynia 248
Large-scale testing (Phase 3)Study completedNCT00290277
What this trial is testing

Evaluate the Immunogenicity & Safety of GSK Biologicals' HPV Vaccine in Female Subjects Aged 10-14 Years

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 300
Next Page
46